Dr. Giedrius Gasiunas

Dr. Giedrius Gasiunas is the co-founder, board member, and CSO at Caszyme, a biotech company specializing in CRISPR-Cas gene editing technology. In 2012, Dr. Gasiunas earned his PhD in Biochemistry from Vilnius University, where he studied under CRISPR pioneer Prof. Virginijus Siksnys. His research focused on the Cas9 protein, demonstrating its role as a programmable RNA-guided DNA endonuclease. In 2016, Dr. Gasiunas has received the young scientist scholarship established by the Lithuanian Academy of Sciences, and in 2017, along with his colleagues, he was awarded the Lithuanian Science Prize. 

Dr. Gasiunas is also a senior researcher and lecturer at Vilnius University Life Science Center, Institute of Biotechnology. With over 17 years of experience in the CRISPR-Cas field, Dr. Gasiunas has contributed to several Cas9-related patents and co-authored 33 scientific publications, which have been cited more than 4,000 times, resulting in an h-index of 21.